Decision Defensibility · Life Sciences · GMP
A complete regulatory failure library for GMP compliance professionals — built from real FDA 483 observation patterns, with Decision Defense Record reconstructions for each.
Regulatory observations frequently occur not because evidence is missing — but because the authorization decision connecting evidence to conclusion was never recorded.
The Questions Your Team Cannot Currently Answer
I don't know if my CAPA disposition rationale will hold up under inspection.
The inspector is going to ask who made this call and I'm not sure we can reconstruct it.
We have six weeks before the audit and I'm not confident our decision trail is complete.
I need something that shows we thought this through — not just that we did it.
These are not documentation problems. They are decision authorization problems. Most organizations can produce SOPs, training records, and CAPA logs. What they cannot reconstruct is who authorized a specific compliance decision, based on what evidence, at what moment, and why that decision was justified.
That is the gap FDA investigators exploit. The Inspection Case File Series shows exactly how it happens — and exactly what the authorization record should have contained.
The Inspection Pattern
The Series
Each case file presents a real FDA 483 observation pattern, the exact inspector question that triggered it, the decision gap analysis, the inspection consequence — and a complete Decision Defense Record showing what the authorization record should have contained.
The complete OOS Investigation Conclusion case file — 483 observation, decision gap analysis, inspection consequence, and full DDR reconstruction. Delivered to your inbox immediately.
Delivered instantly · No spam · Unsubscribe anytime
Check your inbox — Case File #3 is on its way to you now.
Structure of Each Case File
The exact FDA observation language and inspection question that triggered it — written in inspection-grade regulatory prose.
Evidence Present vs. Evidence Missing — the precise authorization elements absent from the record when the investigator arrived.
The real operational cost: retrospective reviews, portfolio reassessments, re-inspection commitments, and the cascade that follows.
A complete Decision Defense Record showing what the authorization record should have contained — inspection-ready, at the moment of decision.
Who This Is For
QA directors and managers responsible for inspection readiness who need to demonstrate that authorization logic — not just activity — is documented at every critical decision point.
Professionals managing process validation, cleaning validation, and computer system validation who need to understand the authorization standard regulators apply to validation conclusions.
RA leaders supporting inspection preparation, 483 response development, and warning letter remediation who need to understand what documented decision authorization looks like in practice.
Organizations that have received an observation related to decision documentation failures — and need to understand both the gap and the standard for remediation.
Manufacturing and quality teams within six months of a Pre-Approval Inspection who need to audit their decision authorization trail before the agency does.
Compliance programs rebuilding quality systems following FDA enforcement — where the authorization record standard is now the baseline, not the aspiration.
Pricing
The complete authorization record library for compliance executives who cannot afford to be wrong in front of an investigator.
Access any single case file. Choose the regulatory area most relevant to your current inspection exposure.
Ten inspection scenarios. Ten Decision Defense Record reconstructions. Every critical GMP decision point — from process validation through complaint disposition — with the exact authorization structure FDA investigators expect to see.